Acceleron Pharma to Present at Two September Investor Conferences
9/12/2011 10:40:44 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced that John Knopf, Ph.D., Chief Executive Officer, will provide a corporate presentation at the Rodman & Renshaw Annual Global Investment Conference and the 2011 UBS Global Life Sciences Conference. The details for each presentation are shown below.
comments powered by